{"id":13017,"date":"2019-04-10T06:45:49","date_gmt":"2019-04-10T10:45:49","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13017"},"modified":"2019-04-10T06:45:49","modified_gmt":"2019-04-10T10:45:49","slug":"pbms-sidestep-the-senates-tough-questions-but-lawmakers-hint-at-legislation","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13017","title":{"rendered":"PBMs sidestep the Senate\u2019s tough questions \u2014 but lawmakers hint at legislation"},"content":{"rendered":"<p>(By Nicholas Florko for ST<em>A<\/em>T)<\/p>\n<p>WASHINGTON \u2014 The much-maligned pharmacy middlemen escaped largely unscathed during a high-profile congressional hearing Tuesday \u2014 but the powerful bipartisan duo behind the hearing now appears intent on legislating, and it looks like increasing transparency will be their primary goal.\u00a0 Continue reading <a href=\"https:\/\/www.statnews.com\/2019\/04\/09\/pbms-sidestep-the-senates-tough-questions\/?utm_source=STAT+Newsletters&amp;utm_campaign=a50f379c62-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-a50f379c62-149624405\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Nicholas Florko for STAT) WASHINGTON \u2014 The much-maligned pharmacy middlemen escaped largely unscathed during a high-profile congressional hearing Tuesday<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,15],"tags":[],"class_list":["post-13017","post","type-post","status-publish","format-standard","hentry","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13017"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13017\/revisions"}],"predecessor-version":[{"id":13018,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13017\/revisions\/13018"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}